Page last updated: 2024-11-01

nimodipine and Atheroembolism

nimodipine has been researched along with Atheroembolism in 1 studies

Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Martin, JB1
Pache, JC1
Treggiari-Venzi, M1
Murphy, KJ1
Gailloud, P1
Puget, E1
Pizzolato, G1
Sugiu, K1
Guimaraens, L1
Théron, J1
Rüfenacht, DA1

Trials

1 trial available for nimodipine and Atheroembolism

ArticleYear
Role of the distal balloon protection technique in the prevention of cerebral embolic events during carotid stent placement.
    Stroke, 2001, Volume: 32, Issue:2

    Topics: Angioplasty, Balloon; Arteriosclerosis; Atherectomy; Carotid Artery, Internal; Carotid Stenosis; Emb

2001